• News
  • BioTech

Calbiotech, Intrinsic Lifesciences form accord

San Diego life science companies Calbiotech Inc. and Intrinsic LifeSciences announced a partnership to develop and validate ELISA kits for hepcidin, a hormone that plays a central role in the regulation of iron in the blood and indicator of iron disorders.

Under the agreement, Calbiotech will produce prototype Intrinsic Hepcidin ELISA kits for technical and clinical validation studies.

Successful development of prototype Intrinsic Hepcidin kits and technical evaluation will lead to a manufacturing agreement between Calbiotech and ILS and open discussion for distribution in select markets of CE Mark Intrinsic Hepcidin ELISA kits targeted for Q4 2014.

User Response
0 UserComments